baber/WOPTO huggingface dataset:
Patent MD-20050186-A (MD)
Title: Method of diagnostics and correction of the patient's encephalon functional state
Inventor: SCORTESCU LIUDMILA
IPC: A61B5/00
Filed: 2005-06-29
Abstract: The invention refers to medicine and may be used in the psychotherapeutic practice. The method of diagnostics and correction of the patient's encephalon functional state includes measurement, registration, analysis of the encephalon's electrical activity indexes and detection of the given indexes deviation from the normative level, carrying out of encephalon's state correction by audiovisual action upon the patient's receptors, his state being subjected to a permanent control in the process of such action. At the same time, the diagnostics and correction is carried out on the basis of analysis of the patient's brain constant potential level, measured and analyzed with the help of the neuroenergometer.
Patent MD-20070334-A (MD)
Title: Method for obtaining thin films of oxide semiconductor
Inventor: KOROTCENKOV GHENADII
IPC: C30B29/16
Filed: 2007-12-12
Abstract: The invention relates to the field of obtaining films of metal oxides, particularly of In2O3, with great dimensions of the flat atomic surface of crystallites. The method for obtaining thin films of oxide semiconductors includes deposition of films by spray pyrolysis at the temperature of 450...550?C from aqueous InCl3 solutions with the metal salt concentration in the solution exceeding 0.2M with subsequent annealing in the neutral or oxygen-containing atmosphere at a temperature exceeding 1000?C.
Patent MX-146158-A (MX)
Inventor: WIXON HAROLD EUGENE
IPC: C11D1/14
Filed: 1974-11-26
Abstract: The viscosity of an aqueous alpha-olefin sulfonate detergent composition is reduced by treating such composition, usually at a concentration of 30 to 60%, with a viscosity reducing proportion, usually from 2 to 20%, of a water soluble inorganic halide salt, preferably sodium chloride. By reducing the viscosity, detergent compositions containing the alpha-olefin sulfonate detergent are made more readily pourable, pumpable and sprayable, facilitating their use in liquid detergents and in spray dried particulate form. Because the addition of halide salt may cause separation into different phases it is possible to increase the concentration of the alpha-olefin sulfonate by utilizing the phase  richer in content of such detergent material.
Patent NZ-187207-A (NZ)
Title: Liquid hard-surface cleaner comprising an anionic detergent and a non-ionic detergent
Inventor: STRAW A
IPC: C11D1/72
Filed: 1978-05-09
Abstract: A liquid hard surface cleaner is disclosed that is impalpable, self-opacifying, enjoys low temperature stability and has satisfactory viscosity and detergency, these being achieved by a particular combination of ingredients and proportions; namely, the composition comprising, by weight, a water-soluble, synthetic, anionic, sulphated or sulphonated detergent salt containing an alkyl radical of 8 to 22 carbon atoms in the molecule, a water-soluble alkylene oxylated nonionic detergent, a water-soluble detergent builder salt and the balance water, the weight ratio of anionic detergent to nonionic detergent being from 0:5 to 6:1 and the weight ratio of builder salt to total detergent being in the range of 1:5 to 5:1.
Patent NZ-222629-A (NZ)
Title: Forming surface of a progressive addition lens
Inventor: SILVA DONALD E
IPC: G02C7/02
Filed: 1987-11-20
Abstract: A method of designing progressive addition lenses is provided in which the surface of the lens is in effect synthesized directly from its specification. A desired pattern of grid lines is produced in which the astigmatism is distributed over the entire pattern of grid lines in a predetermined manner, a standard grid viewing system from which rays are traced is then assumed, and surface normals for each grid crossing are calculated by using the grid object and grid image as known quantities and solving for each surface normal using the law of refraction and determining the surface of the lens from the respective surface normals.
Patent NZ-223350-A (NZ)
Title: 4-hydroxycinnoline-carboxamides and pharmaceutical compositions
Inventor: DORIA GIANFEDERICO
IPC: C07D403/12
Filed: 1988-01-29
Abstract: The invention relates to compounds having the general formula (I)   <CHEM>  wherein  n is zero, 1 or 2;  each of R1 and R2 is independently:     a) hydrogen, halogen, trifluoromethyl or C1-C6 alkyl;   b) hydroxy, C1-C6 alkoxy or C3-C4 alkenyloxy;   c) nitro, amino, formylamino or C2-C8 alkanoylamino;  R3 represents hydrogen or C1-C8 alkyl;  R4 is:       a') C1-C20 alkyl, unsubstituted or substituted by <CHEM> wherein each of Ra and Rb is independently phenyl or C1-C6 alkyl, or Ra and Rb, taken together with the nitrogen atom to which they are linked, form a N-pyrrolidinyl, N-piperazinyl, hexahydroazepin-1-yl, thiomorpholino, morpholino or piperidino ring, wherein said heterocyclic rings may be unsubstituted or substituted by C1-C6 alkyl or phenyl;   b') C5-C10 cycloalkyl, unsubstituted or substituted by methyl; c') 2- or 3-pyrrolidinyl, piperidyl of 2-piperazinyl, wherein said heterocyclic rings may be unsubstituted or substituted by C1-C6 alkyl; d') isoxazolyl or thiazolyl, wherein said heterocyclic rings may be unsubstituted or substituted by C1-C6 alkyl; e') pyridyl, unsubstituted or substituted by one or two substituents chosen independently from halogen, C1-C6 alkyl and C1-C6 alkoxy; or f') phenyl, unsubstituted or substituted by one or two substituents chosen independently from halogen, CF3,C1-C6 alkyl, C1-C6 alkoxy, amino, nitro, formylamino and C2-C8 alkanoylamino, and the pharmaceutically acceptable salts thereof, which possess immunomodulating activity and are useful e.g. in the treatment of neoplastic diseases and acute and chronic infections of both bacterial and viral origin in mammals.
Patent NZ-229630-A (NZ)
Title: Mercaptophenylalkylamide derivatives and pharmaceutical compositions thereof
Inventor: HUGHES IAN
IPC: C07C327/32
Filed: 1989-06-20
Abstract: Novel compounds of formula (I), salts, solvates and hydrates thereof:   <CHEM>  in which: R1 and R2 are independently hydrogen; alkyl; alkoxy; halogen; or CF3;  R3 is hydrogen; acyl, such as   - @-alkyl or - @ - Z, where Z is optionally substituted aryl; or a group R-S- where R is an organic residue such that the group R-S- provides an in vivo-cleavable disulphide bond;  R4 is C3-6 alkyl; R5 is hydrogen; alkyl; -CH2-R10 where R10 is optionally substituted phenyl or heteroaryl;  or a group <CHEM> where R11 is hydrogen; alkyl; or -CH2-Ph where Ph is optionally substituted phenyl; and R12 is hydrogen or alkyl; and  R6 is hydrogen; alkyl; or a group <CHEM> where R13 is hydrogen; or alkyl; and R14 is hydroxy; alkoxy; or -NR7R8 where each of R7 and R8 is hydrogen or alkyl, or R7 and R8 together with the nitrogen atom to which they are bonded form a 5-, 6- or 7- membered ring with an optional oxygen, sulphur or optionally substituted nitrogen atom in the ring; or R5 and R6 are joined together as -(CH2)m- where m is an integer from 4 to 12; X is (CH2)n where n is 0, 1, or 2; and Y is CH2, processes for their preparation and their use as collagenase inhibitors.
Patent NZ-229871-A (NZ)
Title: Circuit breaker contact arm assembly
Inventor: PATON CHARLES RICHARD
IPC: H01H1/22
Filed: 1989-07-07
Abstract: A laminated contact assembly for a circuit breaker with each individual contact assembly having a contact arm portion, carrying a movable main or arching contact and a stationary conductor portion. A flexible shunt connects the contact arm portion to the stationary conductor portion. Intermediate individual contact assemblies are provided with T-shaped slots for receiving square-headed fasteners. This avoids the need to drill and tap holes in the laminated contact arm assembly. Since the individual contact arm assemblies are fastened together, the square-headed fasteners disposed in T-shaped slots in intermediate individual contact arm assemblies is greatly reduced. The flexible shunt is wound from a continuous strip of an electrical conductor.
Patent NZ-235323-A (NZ)
Title: Amide derivatives and pharmaceutical compositions thereof
Inventor: MCCARTHY PETER A
IPC: A61K31/4418
Filed: 1990-09-14
Abstract: Compounds of the formula <CHEM> the pharmaceutically acceptable salts thereof, wherein Q and R<1> are as defined below, and novel carboxylic acid and acid halide intermediates used in the synthesis of such compounds. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.
Patent NZ-239978-A (NZ)
Title: Improved plant transformation by bombardment with microparticles to which agrobacterium has been attached
Inventor: BIDNEY DENNIS
IPC: C12N15/09
Filed: 1991-09-27
Abstract: Bacteria of the species Agrobacterium are applied to particles which are used in a typical particle gun in a manner which retains their viability after the dry-down process involved in microparticle bombardment. When plant materials are bombarded with particles coated with the bacteria, high rates of stable transformation are achieved.
Patent NZ-240377-A (NZ)
Title: Cross-linked haemoglobin and pharmaceutical composition
Inventor: GARLICK ROBERT LEE
IPC: C07K1/107
Filed: 1991-10-29
Abstract: An imidoester, cross-linked hemoglobin composition useful in the transport of oxygen to living cells and being essentially free of any impurities, a P50 of at least 13 mm Hg and predominantly in tetramer form. Preferably, the cross-linked hemoglobin composition has a predominant molecular weight of at least 64,000. The purified and cross-linked hemoglobin has improved cross-link stability to autoxidation and can be used as a blood substitute for mammals or as an oxygen transport fluid.
Patent NZ-242327-A (NZ)
Title: Device for underwater servicing of surfaces such as ships hulls
Inventor: EATHORNE RUSSELL JAMES
IPC: B25J5/00
Filed: 1992-04-10
Abstract: PCT No. PCT/AU92/00160 Sec. 371 Date Dec. 3, 1993 Sec. 102(e) Date Dec. 3, 1993 PCT Filed Apr. 10, 1992 PCT Pub. No. WO92/18379 PCT Pub. Date Oct. 29, 1992.An underwater servicing device includes a substantially hollow housing (30) having an open face (32) whereby the configuration of the open face (32) substantially conforms to the surface of an article to which the housing (30) is to be mounted. A seal (34) is provided about the peripheral edge of the open face (32), as is a pump (42) in fluid communication with the interior of the housing (30) that is capable of evacuating fluid from therewithin and removing such evacuated fluid externally of the device. A mechanism for moving the device from one location on the article to another is also provided, the mechanism being capable of raising the device away from the article. An adjustable air supplier is provided that is capable of allowing air to enter the interior of the housing (30). As water is evacuated from the interior of the housing (30) and air enters, the positive pressure of water external to the housing (30) urges the device against the article such that the seal (34) contacts the article, the further and continuing evacuation of water resulting in a substantially water tight sealing engagement between the seal (34) and the article.
Patent NZ-270449-A (NZ)
Title: 15-deoxyspergualin analogues medicaments thereof
Inventor: RENAUT PATRICE
IPC: A61P37/06
Filed: 1995-02-03
Abstract: 15-deoxy-spergualin analogues of formula (I) and their addn. salts are new. X = (CH2)n; Y = (CH2)4; T = (CH2)2; A = a single bond, -CH2-, -CH2O-, -CH2NH-, -CH(OH)-, -CHF-, or -CH(OCH3)-; n = 6-8. Intermediate cpds. of formula (II) are also claimed. A has the values above or in addn. is CH(OCH2C6H5); R1, R2, R3 = amino-protective gps. of alkoxycarbonyl, benzyloxycarbonyl or benzyl type.
Patent NZ-272189-A (NZ)
Title: Rotary cutter head with replaceable cutting element having inner end constrained between head flanges for pivoting parallel to head axis
Inventor: BESSINGER HENRY JOHN
IPC: A01D34/416
Filed: 1995-05-23
Abstract: A rotatable head for a rotary cutter for use with a replaceable cutting element having an elongate cutting portion (12) and an enlarged retaining portion (13) comprises first (55) and second flange (56) portions defining therebetween a channel (57) in which the said enlarged portion can be disposed with the cutting portion extending outwardly from the channel. The first flange portion has pivotal locating means (50a) for the cutting element retaining portion to allow the said cutting element to pivot about an axis substantially parallel to the access of rotation of the said head through an angle of at least 45 DEG  in a direction opposite to the intended direction of rotation. <IMAGE>
Patent NZ-272883-A (NZ)
Title: Recombinant viral vectors comprising a promoter, recombinase gene and a poly(a) sequence or two recombinase recognizing sequences, origin of replication, promoter, foreign gene and poly(a) sequence and their use in transducing animal cells
Inventor: SAITO IZUMU
IPC: C12N9/00
Filed: 1995-08-29
Abstract: An animal cell is co-transfected with both a recombinant DNA viral vector which bears a promoter, a recombinase gene and a poly(A) sequence and a recombinant DNA viral vector which bears two recombinase-recognition sequences and which further bears an origin of replication, a promoter a foreign gene and a poly(A) sequence, each of which is located between the two recombinase-recognition sequences. Thereafter, in the co-transfected animal cell, a DNA fragment containing the origin of replication, promoter, foreign gene and poly(A) sequence is excised from a vector by the action of recombinase expressed by the other vector. The excised DNA fragment forms a circular DNA molecule which autonomously replicates in the co-transfected animal cell due to the origin of replication, whereby the foreign gene is continuously expressed. Accordingly, when the foreign gene corresponds to a gene which is defective in a patient, the combination of the above two DNA viral vectors is useful in gene therapy, especially in the treatment of a patient with a hereditary disease.
Patent NZ-281586-A (NZ)
Title: Membrane filtration; assembly comprising means for recirculating at least part of the retentate to the feed inlet and means for recirculating at least part of the permeate to a permeate inlet
Inventor: OSTERLAND NIELS
IPC: B01D63/06
Filed: 1995-03-01
Abstract: PCT No. PCT/DK95/00092 Sec. 371 Date Sep. 3, 1996 Sec. 102(e) Date Sep. 3, 1996 PCT Filed Mar. 1, 1995 PCT Pub. No. WO95/23639 PCT Pub. Date Sep. 8, 1995Membrane filtration assembly where the fluid to be filtered is recirculated on the retentate side of a membrane filter and where the filtered fluid, i.e. the permeate, is recirculated on the permeate side of the membrane filter in such a manner that the two streams are cocurrently passed along the membrane filter. The membrane filter comprises several membrane units in form of tubular supporting structures, each supporting structure comprising one or more filter membranes. The membrane units are mounted in parallel inside a common housing in such a manner that one stream flows inside the membrane units while the other stream flows in a space surrounding said membrane units. Each membrane unit is provided with a separate space designed as a narrow passageway on the inner side defined by the membrane unit and on the outer side defined by a channel tube, the inner cross section of which is 4 to 200% larger than the outer cross section of the membrane unit. The assembly is easy to clean, and it is easy to replace the individual membrane units.
Patent NZ-296720-A (NZ)
Title: 1,4-diaryl-3-(hetero)-arylalkanesulphinyl and (-sulphenyl or -sulphonyl)azetidin-2-one derivatives and medicaments
Inventor: MCKITTRICK BRIAN A
IPC: A61P3/06
Filed: 1995-11-15
Abstract: Sulfur-substituted azetidinone hypocholesterolemic agents of the formula    <IMAGE>  I  or a pharmaceutically acceptable salt thereof, wherein: Ar1 is aryl, R10-substituted aryl or heteroaryl; Ar2 is aryl or R4-substituted aryl; Ar3 is aryl or R5-substituted aryl; X and Y are -CH2-, -CH(lower alkyl)- or -C(dilower alkyl)-; R is -OR6, -O(CO)R6, -O(CO)OR9 or -O(CO)NR6R7; R1 is hydrogen, lower alkyl or aryl; or R and R1 together are =O; q is 0 or 1; r is 0, 1 or 2; m and n are 0-5; provided that the sum of m, n and q is 1-5; R4 is selected from lower alkyl, -OR6, -O(CO)R6, -O(CO)OR9, -O(CH2)1-5OR6, -O(CO)NR6R7, -NR6R7, -NR6(CO)R7, -NR6(CO)OR9, -NR6(CO)NR7R8, -NR6SO2R9, -COOR6, -CONR6R7, -COR6, -SO2NR6R7, S(O)0-2R9, -O(CH2)1-10-COOR6, -O(CH2)1-10CONR6R7, -(lower alkylene)-COOR6 and -CH=CH-COOR6; R5 is selected from -OR6, -O(CO)R6, -O(CO)OR9, -O(CH2)1-5OR6, -O(CO)NR6R7, -NR6R7, -NR6(CO)R7, -NR6(CO)OR9, -NR6(CO)NR7R8, -NR6SO2R9, -COOR6, -CONR6R7, -COR6, -SO2NR6R7, S(O)0-2R9, -O(CH2)1-10-COOR6, -O(CH2)1-10CONR6R7, -CF3, -CN, -NO2, halogen, -(lower alkylene)COOR6 and -CH=CH-COOR6; R6, R7 and R8 are H, lower alkyl, aryl or aryl-substituted lower alkyl; R9 is lower alkyl, aryl or aryl-substituted lower alkyl; and R10 is selected from lower alkyl, -OR6, -O(CO)R6, -O(CO)OR9, -O(CH2)1-5OR6, -O(CO)NR6R7, -NR6R7, -NR6(CO)R7, -NR6(CO)OR9, -NR6(CO)NR7R8, -NR6SO2R9, -COOR6, -CONR6R7, -COR6, -SO2NR6R7, S(O)0-2R9, -O(CH2)1-10-COOR6, -O(CH2)1-10CONR6R7, -CF3, -CN, -NO2 and halogen; are disclosed, as well as pharmaceutical compositions containing them, and a method of lowering serum cholesterol by administering said compounds, alone or in combination with a cholesterol biosynthesis inhibitor.
Patent NZ-314491-A (NZ)
Title: Ostomy pouch, inlet and outlet chambers separated by gas permeable liquid impermeable membrane and moisture superabsorbent material covering filter at outlet chamber vent
Inventor: FERREIRA ADOLFO A
IPC: A61F5/441
Filed: 1997-03-26
Abstract: The pouch is formed of first and second thin barrier film walls welded along the periphery to form a waste receptical. One wall has an inlet defined by an attachment ring. The ring mounts the pouch on an adhesive faceplate adapted to adhere to the skin surrounding the stoma. A membrane, formed of material which is gas permeable but transmits little moisture and no liquid, is situated between the walls to separate the receptical into an inlet chamber, where solids, liquid and most moisture are retained, and an outlet chamber into which gas and a small amount of vapor passes. A filter is provided to permit the gas to exit the outlet chamber. A first section of superabsorbent material isolates the filter from the outlet chamber. By absorbing any moisture in the gas before it contacts the filter, blockage of the filter is prevented. A second section of superabsorbant material is provided near the bottom of the output chamber to absorb moisture which otherwise may cause the membrane to stick to the pouch wall, resulting in a substantial reduction of the gas transmissibility of the membrane.
Patent NZ-325051-A (NZ)
Title: Excavating tooth
Inventor: JONES LARREN F
IPC: E02F9/28
Filed: 1996-12-11
Abstract: n excavating tooth for attachment to the digging edge of excavating equipment includes a wear member (12) provided with bearing faces (67, 68, 72) in a socket which extend substantially parallel to the longitudinal axis of the tooth. The bearing faces are formed to widen significantly as they extend rearward to provide board bearing surfaces at the rear ends (84) of the wear member. The bearing faces are placed between converging walls (78, 79) and sidewalls (74, 75) of the socket at obtuse angles thereto to avoid areas of stress concentration. The wear member is further secured to the adapter by locks which ease installation and removal of the wear member.
Patent NZ-326362-A (NZ)
Title: Preparations stimulating nail growth
Inventor: BOHN MANFRED
IPC: A61K9/70
Filed: 1997-01-23
Abstract: PCT No. PCT/EP97/00311 Sec. 371 Date Feb. 11, 1998 Sec. 102(e) Date Feb. 11, 1998 PCT Filed Jan. 23, 1997 PCT Pub. No. WO97/28790 PCT Pub. Date Aug. 14, 1997A nail varnish comprising a compound having a vasodilating action and a water-insoluble film-forming agent is suitable for treatment of growth disturbances of the nail.
Patent NZ-330652-A (NZ)
Title: Brickwork ventilation device with open rear portion and louvred front portion, and formed of moulded settable material
Inventor: DEEGAN STEPHEN JAMES
IPC: E04F17/00
Filed: 1998-06-11
Abstract: The device consists of a hollow body to be inserted between bricks or blocks of the outer leaf of a cavity wall.
Patent NZ-332441-A (NZ)
Title: Top gripping article carrier blank having lower panels comprising side and end panels and upper panels with retaining means
Inventor: LE BRAS PHILIPPE
IPC: B65B21/24
Filed: 1995-09-21
Abstract: A blank 10 for forming an article carrier of the top gripping type comprises lower panels including a first 16 and second 22 side panel and end panels 42a, 42c for wrapping around the sides and ends of a packaged article.  A first upper panel 12 is hingably attached to first side panel 16 along a first fold line 52 and a second upper panel 26 is hingably attached to second side panel 22 along a second fold line 54. Each of first and second upper panels 12, 26 have retaining means including an aperture 28 defining an aperture rim extending into a respective one of first upper panel 12 and second upper panel 26 across the respective fold line 52, 54 thereof to cooperate with the article top upon folding of upper panel 12, 26 about fold line 52, 54 to retain the article in the formed carrier.
Patent NZ-334346-A (NZ)
Title: Olanzapine dihydrate D comprising 2-methyl-4-(4-methyl-1-piperazinyl)-1OH-thieno[2,3-b][1,5]benzodiazepine and a formulation for use in treating central nervous system disorders
Inventor: LARSEN SAMUEL D
IPC: A61K31/55
Filed: 1997-09-18
Abstract: A crystalline dihydrate D of 2-methyl-4-(4-methyl-1-piperazinyl)-1OH-thieno[2,3-b][[1,5]benzodiazepine (referred to as olanzapine) that is useful for preparing an aqueous olanzapine formulation.  Pharmaceutical compositions containing olanzapine and their use in treating anxiety, schizophrenia, functional bowel disorder, and psychosis in a mammal are also described.
Patent NZ-500936-A (NZ)
Title: Retroviral vector particles produced in a baculovirus expression system capable of delivering a nucleotide sequence of interest (NOI)
Inventor: KINGSMAN ALAN JOHN
IPC: A61P31/14
Filed: 1998-06-04
Abstract: A composition comprising at least one baculoviral vector and at least one polynucleotides sequence encoding a retroviral vector genome; wherein the polynucleotides sequence encoding the retroviral vector genome is operably linked to a promoter in the baculoviral vector. The promoter in the baculoviral vector comprises an RNA transcription start site for the retroviral vector genome; such that the polynucleotides sequence encoding the retroviral vector genome is capable of being transcribed and packaged into an infectious retroviral particle.
Patent NZ-501251-A (NZ)
Title: Sertraline salts and sustained-release dosage forms of sertraline
Inventor: FRIESEN DWAYNE THOMAS
IPC: A61K9/26
Filed: 1998-06-15
Abstract: Sustained release dosage forms of sertraline, or pharmaceutically acceptable salts thereof are disclosed.  Sertraline is released at a rate of between 0.02 mgA/hr/kg and 0.6 mgA/hr/kg, or between 1 mgA/hr and 40 mgA/hr, where mgA is the amount of active sertraline. The dosage form must not release more than 70% of the sertraline in the first hour following administration. The dosage form is suitable for oral administration to a mammal.
Patent NZ-508221-A (NZ)
Title: Method of manufacturing a light guide
Inventor: JOSEPH EDMOND KENNETH
IPC: B29C43/10
Filed: 1999-05-17
Abstract: A method of manufacturing light guide by filling a polymer tube with a monomeric mixture then pressurising and heating the full length of the polymer tube to initiate and maintain polymerisation in the tube. An apparatus for performing the method is also described in which the polymer tube is placed in a reaction vessel and a temperature controlled fluid is circulated to regulate the temperature in the vessel.